Kruti Patel

Kruti Patel

Company: Pfizer

Job title: Principal Scientist


Determining how Immunosuppressants can be Optimized to Achieve Gene Therapy Durability 9:30 am

• Mitigate initial reaction to transgene to achieve short term durability • Does it enable patients with prior AAV immunological responses to be doses with gene therapy treatments? • Is controlling T regulatory cells, and purely T cell depletion the main thing to impact the antibody response?Read more

day: Day One AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.